The FDA approved donanemab-azbt injection for the treatment of Alzheimer’s disease in patients who have mild cognitive impairment or mild dementia …
FDA Approves Kisunla to Treat Early Alzheimer’s Disease – Pharmacy Practice News
About the Author:
The FDA approved donanemab-azbt injection for the treatment of Alzheimer’s disease in patients who have mild cognitive impairment or mild dementia …
Leave A Comment